Natu.Care Omega-3 550 mg: ingredient analysis, reviews, properties

On the packaging of this dietary supplement, you will find information that it should not be taken by pregnant women. This is due to concerns for the safety of the future mother and the child. We do not know if you have any chronic illnesses, what medications and other dietary supplements you are taking, nor do we know your health status and the course of your pregnancy. This is information for your doctor, who should decide whether you can safely use the dietary supplement with omega-3 fatty acids.

You do not need to take breaks from supplementation. Our omega-3 dietary supplement can be used all year round, especially if you do not eat oily fish, which are the best source of omega-3 fatty acids in your diet.

Yes, you can take omega-3 fatty acids at night and at any time of the day, as it does not matter. There is another point to consider – consume the capsule with foods containing healthy fats, as this increases the bioavailability of omega-3 fatty acids, facilitating their absorption by the body.

Omega-3 fatty acids are important in the diets of children and adolescents, especially if they do not eat oily fish, which are their best source. However, any supplementation for children or teenagers should be discussed with a doctor. The composition of our omega-3 fatty acids (both the 550 mg variant and 750 mg Premium) is safe, tested, and free from contaminants, but let the doctor decide whether your child needs omega-3s. They know best about their health status, medications, other supplements, illnesses, diet, and lifestyle, so they will advise you accordingly.

Yes, vegans and vegetarians, as well as those who eat little fish, should supplement omega-3 fatty acids because:

• A plant-based diet mainly provides ALA, not DHA and EPA,
• plant-based sources of omega-3 fatty acids are not as well absorbed by the body as those of animal origin, specifically from oily fish,
• oily fish are the best source of omega-3; for those on a plant-based diet, marine algae are recommended.

Follow a few rules to ensure effective and enjoyable omega-3 supplementation:

• Do not wash down the supplement with coffee or black tea, as they reduce the absorption of some nutrients.
• Do not take the capsule on an empty stomach – this does not promote the absorption of omega-3s and may cause unpleasant belching.
• Avoid alcohol consumption and smoking, as they deplete omega-3 fatty acids from the body.
• Keep the packaging tightly closed and store in a dry, cool, and dark place to preserve the quality of omega-3 fatty acids for longer.

To avoid fishy burps, take the capsule at the beginning of a substantial meal, such as lunch. Ensure the presence of healthy fats in your diet, such as avocado, nuts, seeds, eggs, and soy.

(BIOHAZ), E. (2010). Scientific Opinion on Fish Oil for Human Consumption. Food Hygiene, including Rancidity. EFSA Journal, 8. https://doi.org/10.2903/j.efsa.2010.1874

7 Things To Know About Omega-3 Fatty Acids. (n.d.). NCCIH. Retrieved 27 November 2023, from https://www.nccih.nih.gov/health/tips/things-to-know-about-omega-fatty-acids

A fish a day, keeps the cardiologist away! – A review of the effect of omega-3 fatty acids in the cardiovascular system – PMC. (n.d.). Retrieved 27 November 2023, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712371/

Abd Allah, E. S. H., Gomaa, A. M. S., & Sayed, M. M. (2014). The effect of omega-3 on cognition in hypothyroid adult male rats. Acta Physiologica Hungarica, 101(3), 362–376. https://doi.org/10.1556/APhysiol.101.2014.3.11

Abdelhamid, A., Hooper, L., Sivakaran, R., Hayhoe, R. P. G., & Welch, A. A. (2019). The relationship between omega-3, omega-6 and total polyunsaturated fat and musculoskeletal health and functional status in adults: A systematic review and meta-analysis of RCTs. Calcified Tissue International, 105(4). https://doi.org/10.1007/s00223-019-00584-3

Abdelnour, E., Jansen, M. O., & Gold, J. A. (2022). ADHD diagnostic trends: Increased recognition or overdiagnosis? Missouri Medicine, 119(5), 467–473.

Abdullah, M., Jowett, B., Whittaker, P. J., & Patterson, L. (2019). The effectiveness of omega-3 supplementation in reducing ADHD associated symptoms in children as measured by the Conners’ rating scales: A systematic review of randomised controlled trials. Journal of Psychiatric Research, 110, 64–73. https://doi.org/10.1016/j.jpsychires.2018.12.002

AbuMweis, S., Abu Omran, D., Al-Shami, I., & Jew, S. (2021). The ratio of eicosapentaenoic acid to docosahexaenoic acid as a modulator for the cardio-metabolic effects of omega-3 supplements: A meta-regression of randomised clinical trials. Complementary Therapies in Medicine, 57, 102662. https://doi.org/10.1016/j.ctim.2021.102662

Allam-Ndoul, B., Guénard, F., Barbier, O., & Vohl, M.-C. (2017). Effect of different concentrations of omega-3 fatty acids on stimulated THP-1 macrophages. Genes & Nutrition, 12(1), 7. https://doi.org/10.1186/s12263-017-0554-6

Amjad Khan, W., Chun-Mei, H., Khan, N., Iqbal, A., Lyu, S.-W., & Shah, F. (2017). Bioengineered plants can be a useful source of omega-3 fatty acids. BioMed Research International, 2017, 7348919. https://doi.org/10.1155/2017/7348919

An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity – PMC. (n.d.). Retrieved 27 November 2023, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808858/

Anderson, G. J., Connor, W. E., & Corliss, J. D. (1990). Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina. Pediatric Research, 27(1), 89–97. https://doi.org/10.1203/00006450-199001000-00023

Asbaghi, O., Choghakhori, R., & Abbasnezhad, A. (2019). Effect of omega-3 and vitamin E co-supplementation on serum lipids concentrations in overweight patients with metabolic disorders: A systematic review and meta-analysis of RCTs. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(4), 2525–2531. https://doi.org/10.1016/j.dsx.2019.07.001

Association between dietary omega-3 fatty acid intake and depression in postmenopausal women – PMC. (n.d.). Retrieved 27 November 2023, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313386/

Austria, J. A., Richard, M. N., Chahine, M. N., Edel, A. L., Malcolmson, L. J., Dupasquier, C. M. C., & Pierce, G. N. (2008). Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed. Journal of the American College of Nutrition, 27(2), 214–221. https://doi.org/10.1080/07315724.2008.10719693

Avallone, R., Vitale, G., & Bertolotti, M. (2019). Omega-3 fatty acids and neurodegenerative diseases: New evidence in clinical trials. International Journal of Molecular Sciences, 20(17), 4256. https://doi.org/10.3390/ijms20174256

Backes, J., Anzalone, D., Hilleman, D., & Catini, J. (2016). The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridaemia. Lipids in Health and Disease, 15(1), 118. https://doi.org/10.1186/s12944-016-0286-4

Balanzá-Martínez, V., Fries, G. R., Colpo, G. D., Silveira, P. P., Portella, A. K., Tabares-Seisdedos, R., & Kapczinski, F. (2011). Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Review of Neurotherapeutics, 11(7), 1029–1047. https://doi.org/10.1586/ern.11.42

Balbás, G. M., Regaña, M. S., & Millet, P. U. (2011). Study on the use of omega-3 fatty acids as a therapeutic supplement in treatment of psoriasis. Clinical, Cosmetic and Investigational Dermatology, 4, 73–77. https://doi.org/10.2147/CCID.S17220

Balić, A., Vlašić, D., Žužul, K., Marinović, B., & Bukvić Mokos, Z. (2020). Omega-3 versus omega-6 polyunsaturated fatty acids in the prevention and treatment of inflammatory skin diseases. International Journal of Molecular Sciences, 21(3), Article 3. https://doi.org/10.3390/ijms21030741

Behboudi-Gandevani, S., Hariri, F.-Z., & Moghaddam-Banaem, L. (2018). The effect of omega 3 fatty acid supplementation on premenstrual syndrome and health-related quality of life: A randomised clinical trial. Journal of Psychosomatic Obstetrics and Gynaecology, 39(4), 266–272. https://doi.org/10.1080/0167482X.2017.1348496

Boone, K. M., Klebanoff, M. A., Rogers, L. K., Rausch, J., Coury, D. L., & Keim, S. A. (2022). Effects of omega-3-6-9 fatty acid supplementation on behaviour and sleep in preterm toddlers with autism symptomatology: Secondary analysis of a randomised clinical trial. Early Human Development, 169, 105588. https://doi.org/10.1016/j.earlhumdev.2022.105588

Bozzatello, P., Brignolo, E., De Grandi, E., & Bellino, S. (2016). Supplementation with omega-3 fatty acids in psychiatric disorders: A review of literature data. Journal of Clinical Medicine, 5(8), Article 8. https://doi.org/10.3390/jcm5080067

Bradberry, J. C., & Hilleman, D. E. (2013). Overview of omega-3 fatty acid therapies. Pharmacy and Therapeutics, 38(11), 681–691.

Bryhn, M., Hansteen, H., Schanche, T., & Aakre, S. E. (2006). The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 75(1), 19–24. https://doi.org/10.1016/j.plefa.2006.04.003

Calder, P. C. (2010). Omega-3 fatty acids and inflammatory processes. Nutrients, 2(3), 355–374. https://doi.org/10.3390/nu2030355

Calder, P. C., Waitzberg, D. L., Klek, S., & Martindale, R. G. (2020). Lipids in parenteral nutrition: Biological aspects. Journal of Parenteral and Enteral Nutrition, 44(S1), S21–S27. https://doi.org/10.1002/jpen.1756

Callaway, J., Schwab, U., Harvima, I., Halonen, P., Mykkänen, O., Hyvönen, P., & Järvinen, T. (2005). Efficacy of dietary hempseed oil in patients with atopic dermatitis. The Journal of Dermatological Treatment, 16(2), 87–94. https://doi.org/10.1080/09546630510035832

Campoy, C., Escolano-Margarit, M. V., Anjos, T., Szajewska, H., & Uauy, R. (2012). Omega 3 fatty acids on child growth, visual acuity and neurodevelopment. British Journal of Nutrition, 107(S2), S85–S106. https://doi.org/10.1017/S0007114512001493

Canhada, S., Castro, K., Perry, I. S., & Luft, V. C. (2018). Omega-3 fatty acids’ supplementation in Alzheimer’s disease: A systematic review. Nutritional Neuroscience, 21(8), 529–538. https://doi.org/10.1080/1028415X.2017.1321813

Castro Dos Santos, N. C., Furukawa, M. V., Oliveira-Cardoso, I., Cortelli, J. R., Feres, M., Van Dyke, T., & Rovai, E. S. (2022). Does the use of omega-3 fatty acids as an adjunct to non-surgical periodontal therapy provide additional benefits in the treatment of periodontitis? A systematic review and meta-analysis. Journal of Periodontal Research, 57(3), 435–447. https://doi.org/10.1111/jre.12984

Chae, M., & Park, K. (2021). Association between dietary omega-3 fatty acid intake and depression in postmenopausal women. Nutrition Research and Practice, 15(4), 468. https://doi.org/10.4162/nrp.2021.15.4.468

Chang, J. P.-C., Su, K.-P., Mondelli, V., & Pariante, C. M. (2018). Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: A systematic review and meta-analysis of clinical trials and biological studies. Neuropsychopharmacology, 43(3), 534–545. https://doi.org/10.1038/npp.2017.160

Chauhan, S., Kodali, H., Noor, J., Ramteke, K., & Gawai, V. (2017). Role of omega-3 fatty acids on lipid profile in diabetic dyslipidaemia: A single-blind, randomised clinical trial. Journal of Clinical and Diagnostic Research : JCDR, 11(3), OC13–OC16. https://doi.org/10.7860/JCDR/2017/20628.9449

Chen, B., & Dong, S. (2022). Mercury contamination in fish and its effects on the health of pregnant women and their fetuses, and guidance for fish consumption – A narrative review. International Journal of Environmental Research and Public Health, 19(23), 15929. https://doi.org/10.3390/ijerph192315929

Ciubotaru, I., Lee, Y.-S., & Wander, R. C. (2003). Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. The Journal of Nutritional Biochemistry, 14(9), 513–521. https://doi.org/10.1016/s0955-2863(03)00101-3

Coletta, J. M., Bell, S. J., & Roman, A. S. (2010). Omega-3 fatty acids and pregnancy. Reviews in Obstetrics and Gynecology, 3(4), 163–171.

Combarros, D., Castilla-Castaño, E., Lecru, L. A., Pressanti, C., Amalric, N., & Cadiergues, M. C. (2020). A prospective, randomised, double-blind, placebo-controlled evaluation of the effects of an n-3 essential fatty acids supplement (Agepi® ω3) on clinical signs, and fatty acid concentrations in the erythrocyte membrane, hair shafts and skin surface of dogs with poor quality coats. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 159, 102140. https://doi.org/10.1016/j.plefa.2020.102140

Conquer, J. A., & Holub, B. J. (1996). Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. The Journal of Nutrition, 126(12), 3032–3039. https://doi.org/10.1093/jn/126.12.3032

Craddock, J. C., Probst, Y. C., Neale, E. P., & Peoples, G. E. (2022). A cross-sectional comparison of the whole blood fatty acid profile and omega-3 index of male vegan and omnivorous endurance athletes. Journal of the American Nutrition Association, 41(3), 333–341. https://doi.org/10.1080/07315724.2021.1886196

Crupi, R., & Cuzzocrea, S. (2022). Role of EPA in inflammation: Mechanisms, effects, and clinical relevance. Biomolecules, 12(2), 242. https://doi.org/10.3390/biom12020242

Davidson, M. H., Johnson, J., Rooney, M. W., Kyle, M. L., & Kling, D. F. (2012). A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova® compared to Lovaza® in a pharmacokinetic single-dose evaluation) study. Journal of Clinical Lipidology, 6(6), 573–584. https://doi.org/10.1016/j.jacl.2012.01.002

Davidson, M. H., Kling, D., & Maki, K. C. (2011). Novel developments in omega-3 fatty acid-based strategies. Current Opinion in Lipidology, 22(6), 437–444. https://doi.org/10.1097/MOL.0b013e32834bd642

de Lorgeril, M., & Salen, P. (2012). New insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acids. BMC Medicine, 10(1), 50. https://doi.org/10.1186/1741-7015-10-50

de Wilde, M. C., Vellas, B., Girault, E., Yavuz, A. C., & Sijben, J. W. (2017). Lower brain and blood nutrient status in Alzheimer’s disease: Results from meta-analyses. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 3(3), 416–431. https://doi.org/10.1016/j.trci.2017.06.002

Derbyshire, E. (2017). Do omega-3/6 fatty acids have a therapeutic role in children and young people with ADHD? Journal of Lipids, 2017, 6285218. https://doi.org/10.1155/2017/6285218

Desbois, A. P., & Lawlor, K. C. (2013). Antibacterial activity of long-chain polyunsaturated fatty acids against Propionibacterium acnes and Staphylococcus aureus. Marine Drugs, 11(11), Article 11. https://doi.org/10.3390/md11114544

Deutch, B. (1995). Menstrual pain in Danish women correlated with low n-3 polyunsaturated fatty acid intake. European Journal of Clinical Nutrition, 49(7), 508–516.

Diana, F. M., & Fitria, N. (2022). Association of omega 3 and omega 6 and child development: A systematic review. Nutrición Clínica y Dietética Hospitalaria, 42(2), Article 2. https://doi.org/10.12873/422fivi

Dietary omega-6/omega-3 polyunsaturated fatty acid (PUFA) and omega-3 are associated with general and abdominal obesity in adults: UK National Diet and Nutritional Survey – [Scite report]. (n.d.). Retrieved 27 November 2023, from https://scite.ai/reports/dietary-omega-6-omega-3-polyunsaturated-fatty-acid-A3rjvKNe?showReferences=true

Djuricic, I., & Calder, P. C. (2021). Beneficial outcomes of omega-6 and omega-3 polyunsaturated fatty acids on human health: An update for 2021. Nutrients, 13(7), 2421. https://doi.org/10.3390/nu13072421

Downie, L. E., Gad, A., Wong, C. Y., Gray, J. H. V., Zeng, W., Jackson, D. C., & Vingrys, A. J. (2018). Modulating contact lens discomfort with anti-inflammatory approaches: A randomised controlled trial. Investigative Ophthalmology & Visual Science, 59(8), 3755–3766. https://doi.org/10.1167/iovs.18-24758

Downie, L. E., & Vingrys, A. J. (2018). Oral omega-3 supplementation lowers intraocular pressure in normotensive adults. Translational Vision Science & Technology, 7(3), 1. https://doi.org/10.1167/tvst.7.3.1

Dry Eye Assessment and Management Study Research Group, Asbell, P. A., Maguire, M. G., Pistilli, M., Ying, G., Szczotka-Flynn, L. B., Hardten, D. R., Lin, M. C., & Shtein, R. M. (2018). N-3 fatty acid supplementation for the treatment of dry eye disease. The New England Journal of Medicine, 378(18), 1681–1690. https://doi.org/10.1056/NEJMoa1709691

Dyall, S. C. (2015). Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA and DHA. Frontiers in Aging Neuroscience, 7, 52. https://doi.org/10.3389/fnagi.2015.00052

Dyall, S. C., & Michael-Titus, A. T. (2008). Neurological benefits of omega-3 fatty acids. NeuroMolecular Medicine, 10(4), 219–235. https://doi.org/10.1007/s12017-008-8036-z

Dyerberg, J., Madsen, P., Møller, J. M., Aardestrup, I., & Schmidt, E. B. (2010). Bioavailability of marine n-3 fatty acid formulations. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 83(3), 137–141. https://doi.org/10.1016/j.plefa.2010.06.007

Ebrahimi, M., Ghayour-Mobarhan, M., Rezaiean, S., Hoseini, M., Parizade, S. M. R., Farhoudi, F., Hosseininezhad, S. J., Tavallaei, S., Vejdani, A., Azimi-Nezhad, M., Shakeri, M. T., Rad, M. A., Mobarra, N., Kazemi-Bajestani, S. M. R., & Ferns, G. A. A. (2009). Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity. Acta Cardiologica, 64(3), 321–327. https://doi.org/10.2143/AC.64.3.2038016

Effects of omega-3 polyunsaturated fatty acids on platelet function in healthy subjects and subjects with cardiovascular disease – PubMed. (n.d.). Retrieved 27 November 2023, from https://pubmed.ncbi.nlm.nih.gov/23329646/

EFSA assesses safety of long-chain omega-3 fatty acids | EFSA. (2012, 27 July). https://www.efsa.europa.eu/en/press/news/120727

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). (2012). Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA Journal, 10(7), 2815. https://doi.org/10.2903/j.efsa.2012.2815

Elbahnasawy, A. S., Valeeva, E. R., El-Sayed, E. M., & Stepanova, N. V. (2019). Protective effect of dietary oils containing omega-3 fatty acids against glucocorticoid-induced osteoporosis. Journal of Nutrition and Health, 52(4), 323–331. https://doi.org/10.4163/jnh.2019.52.4.323

Eslick, G. D., Howe, P. R. C., Smith, C., Priest, R., & Bensoussan, A. (2009). Benefits of fish oil supplementation in hyperlipidaemia: A systematic review and meta-analysis. International Journal of Cardiology, 136(1), 4–16. https://doi.org/10.1016/j.ijcard.2008.03.092

Fabian, C. J., Kimler, B. F., & Hursting, S. D. (2015). Omega-3 fatty acids for breast cancer prevention and survivorship. Breast Cancer Research, 17(1), 62. https://doi.org/10.1186/s13058-015-0571-6

Fatty Acids—An overview | ScienceDirect Topics. (n.d.). Retrieved 27 November 2023, from https://www.sciencedirect.com/topics/earth-and-planetary-sciences/fatty-acids

Flock, M. R., Harris, W. S., & Kris-Etherton, P. M. (2013). Long-chain omega-3 fatty acids: Time to establish a dietary reference intake. Nutrition Reviews, 71(10), 692–707. https://doi.org/10.1111/nure.12071

Fortin, P. R., Lew, R. A., Liang, M. H., Wright, E. A., Beckett, L. A., Chalmers, T. C., & Sperling, R. I. (1995). Validation of a meta-analysis: The effects of fish oil in rheumatoid arthritis. Journal of Clinical Epidemiology, 48(11), 1379–1390. https://doi.org/10.1016/0895-4356(95)00028-3

Friday, K. E., Childs, M. T., Tsunehara, C. H., Fujimoto, W. Y., Bierman, E. L., & Ensinck, J. W. (1989). Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes. Diabetes Care, 12(4), 276–281. https://doi.org/10.2337/diacare.12.4.276

Fritsche, K. L. (2015). The science of fatty acids and inflammation. Advances in Nutrition, 6(3), 293S-301S. https://doi.org/10.3945/an.114.006940

Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., Miller, A. H., Mantovani, A., Weyand, C. M., Barzilai, N., Goronzy, J. J., Rando, T. A., Effros, R. B., Lucia, A., Kleinstreuer, N., & Slavich, G. M. (2019). Chronic inflammation in the aetiology of disease across the lifespan. Nature Medicine, 25(12), 1822–1832. https://doi.org/10.1038/s41591-019-0675-0

Ghasemi Fard, S., Wang, F., Sinclair, A. J., Elliott, G., & Turchini, G. M. (2019). How does high DHA fish oil affect health? A systematic review of evidence. Critical Reviews in Food Science and Nutrition, 59(11), 1684–1727. https://doi.org/10.1080/10408398.2018.1425978

Goldberg, R. J., & Katz, J. (2007). A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain, 129(1–2), 210–223. https://doi.org/10.1016/j.pain.2007.01.020

González, F. E., & Báez, R. V. (2017). IN TIME: IMPORTÂNCIA DOS ÔMEGA 3 NA NUTRIÇÃO INFANTIL. Revista Paulista de Pediatria, 35, 03–04. https://doi.org/10.1590/1984-0462/;2017;35;1;00018

Greenberg, J. A., Bell, S. J., & Ausdal, W. V. (2008). Omega-3 fatty acid supplementation during pregnancy. Reviews in Obstetrics and Gynecology, 1(4), 162–169.

Grosso, G., Galvano, F., Marventano, S., Malaguarnera, M., Bucolo, C., Drago, F., & Caraci, F. (2014). Omega-3 fatty acids and depression: Scientific evidence and biological mechanisms. Oxidative Medicine and Cellular Longevity, 2014, 313570. https://doi.org/10.1155/2014/313570

Guesnet, P., & Alessandri, J.-M. (2011). Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) – Implications for dietary recommendations. Biochimie, 93(1), 7–12. https://doi.org/10.1016/j.biochi.2010.05.005

Guo, Y., Ma, B., Li, X., Hui, H., Zhou, Y., Li, N., & Xie, X. (2022). Omega-3 polyunsaturated fatty acids can reduce IL-6 and TNF levels in patients with cancer. The British Journal of Nutrition, 1–34. https://doi.org/10.1017/S0007114522000575

Gupta, R., Lakshmy, R., Abraham, R., Reddy, K., Jeemon, P., & Prabhakaran, D. (2013). Serum omega-6/omega-3 ratio and risk markers for cardiovascular disease in an industrial population of Delhi. Food and Nutrition Sciences, 4(9), Article 9. https://doi.org/10.4236/fns.2013.49A1015

GUS. (n.d.-a). Statystyka zgonów i umieralności z powodu chorób układu krążenia. stat.gov.pl. Retrieved 27 November 2023, from https://stat.gov.pl/obszary-tematyczne/ludnosc/ludnosc/statystyka-zgonow-i-umieralnosci-z-powodu-chorob-ukladu-krazenia,22,1.html

GUS. (n.d.-b). Umieralność w 2021 roku. Zgony według przyczyn – Dane wstępne. stat.gov.pl. Retrieved 27 November 2023, from https://stat.gov.pl/obszary-tematyczne/ludnosc/statystyka-przyczyn-zgonow/umieralnosc-w-2021-roku-zgony-wedlug-przyczyn-dane-wstepne,10,3.html

Helland, I. B., Smith, L., Saarem, K., Saugstad, O. D., & Drevon, C. A. (2003). Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics, 111(1), e39-44. https://doi.org/10.1542/peds.111.1.e39

Hidaka, B. H., Li, S., Harvey, K. E., Carlson, S. E., Sullivan, D. K., Kimler, B. F., Zalles, C. M., & Fabian, C. J. (2015). Omega-3 and omega-6 fatty acids in blood and breast tissue of high-risk women and association with atypical cytomorphology. Cancer Prevention Research, 8(5), 359–364. https://doi.org/10.1158/1940-6207.CAPR-14-0351

Horrocks, L. A., & Yeo, Y. K. (1999). Health benefits of docosahexaenoic acid (DHA). Pharmacological Research, 40(3), 211–225. https://doi.org/10.1006/phrs.1999.0495

Innes, J. K., & Calder, P. C. (2018). Omega-6 fatty acids and inflammation. Prostaglandins, Leukotrienes and Essential Fatty Acids, 132, 41–48. https://doi.org/10.1016/j.plefa.2018.03.004

Innis, S. M. (2008). Dietary omega 3 fatty acids and the developing brain. Brain Research, 1237, 35–43. https://doi.org/10.1016/j.brainres.2008.08.078

Jerosch, J. (2011). Effects of glucosamine and chondroitin sulfate on cartilage metabolism in OA: Outlook on other nutrient partners especially omega-3 fatty acids. International Journal of Rheumatology, 2011, e969012. https://doi.org/10.1155/2011/969012

Jiang, H., Shi, X., Fan, Y., Wang, D., Li, B., Zhou, J., Pei, C., & Ma, L. (2021). Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration. Clinical Nutrition (Edinburgh, Scotland), 40(12), 5662–5673. https://doi.org/10.1016/j.clnu.2021.10.005

Johnson, M. (2014). Omega-3, omega-6 and omega-9 fatty acids: Implications for cardiovascular and other diseases. Journal of Glycomics & Lipidomics, 04(04). https://doi.org/10.4172/2153-0637.1000123

Kangari, H., Eftekhari, M. H., Sardari, S., Hashemi, H., Salamzadeh, J., Ghassemi-Broumand, M., & Khabazkhoob, M. (2013). Short-term consumption of oral omega-3 and dry eye syndrome. Ophthalmology, 120(11), 2191–2196. https://doi.org/10.1016/j.ophtha.2013.04.006

Karcz, K., Królak-Olejnik, B., & Paluszyńska, D. (2019). [Vegetarian diet in pregnancy and lactation – Safety and rules of balancing meal plan in the aspect of optimal fetal and infant development]. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego, 46(271), 45–50.

Kavyani, Z., Musazadeh, V., Fathi, S., Hossein Faghfouri, A., Dehghan, P., & Sarmadi, B. (2022). Efficacy of the omega-3 fatty acids supplementation on inflammatory biomarkers: An umbrella meta-analysis. International Immunopharmacology, 111, 109104. https://doi.org/10.1016/j.intimp.2022.109104

Kawamura, A., Ooyama, K., Kojima, H., Kachi, H., Abe, T., Amano, K., & Aoyama, T. (2011). Dietary supplementation of gamma-linolenic acid improves skin parameters in subjects with dry skin and mild atopic dermatitis. Journal of Oleo Science, 60(12), 597–607. https://doi.org/10.5650/jos.60.597

Kendall, A. C., Kiezel-Tsugunova, M., Brownbridge, L. C., Harwood, J. L., & Nicolaou, A. (2017). Lipid functions in skin: Differential effects of n-3 polyunsaturated fatty acids on cutaneous ceramides, in a human skin organ culture model. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1859(9, Part B), 1679–1689. https://doi.org/10.1016/j.bbamem.2017.03.016

Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617–627. https://doi.org/10.1001/archpsyc.62.6.617

Khalili, L., Valdes-Ramos, R., & Harbige, L. S. (2021). Effect of n-3 (Omega-3) polyunsaturated fatty acid supplementation on metabolic and inflammatory biomarkers and body weight in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of RCTs. Metabolites, 11(11), 742. https://doi.org/10.3390/metabo11110742

Kiecolt-Glaser, J. K., Belury, M. A., Andridge, R., Malarkey, W. B., & Glaser, R. (2011). Omega-3 supplementation lowers inflammation and anxiety in medical students: A randomised controlled trial. Brain, Behavior, and Immunity, 25(8), 1725–1734. https://doi.org/10.1016/j.bbi.2011.07.229

Kim, H. (2011). Glutamine as an immunonutrient. Yonsei Medical Journal, 52(6), 892–897. https://doi.org/10.3349/ymj.2011.52.6.892

Kruger, M. C., Coetzer, H., de Winter, R., Gericke, G., & van Papendorp, D. H. (1998). Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milan, Italy), 10(5), 385–394. https://doi.org/10.1007/BF03339885

Krupa, K., Fritz, K., & Parmar, M. (2023). Omega-3 fatty acids. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK564314/

Kucukgoncu, S., Zhou, E., Lucas, K. B., & Tek, C. (2017). Alpha-lipoic acid (ALA) as a supplement for weight loss: Results from a meta-analysis of randomised controlled trials. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity, 18(5), 594–601. https://doi.org/10.1111/obr.12528

Lane, K. E., Wilson, M., Hellon, T. G., & Davies, I. G. (2022). Bioavailability and conversion of plant-based sources of omega-3 fatty acids – a scoping review to update supplementation options for vegetarians and vegans. Critical Reviews in Food Science and Nutrition, 62(18), 4982–4997. https://doi.org/10.1080/10408398.2021.1880364

Lavialle, M., Champeil-Potokar, G., Alessandri, J. M., Balasse, L., Guesnet, P., Papillon, C., Pévet, P., Vancassel, S., Vivien-Roels, B., & Denis, I. (2008). An (n-3) polyunsaturated fatty acid-deficient diet disturbs daily locomotor activity, melatonin rhythm, and striatal dopamine in Syrian hamsters. The Journal of Nutrition, 138(9), 1719–1724. https://doi.org/10.1093/jn/138.9.1719

Lawson, L. D., & Hughes, B. G. (1988). Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal. Biochemical and Biophysical Research Communications, 156(2), 960–963. https://doi.org/10.1016/s0006-291x(88)80937-9

Lefloch, C., Cheniti, A., Connétable, S., Piccardi, N., Vincenzi, C., & Tosti, A. (2015). Effect of a nutritional supplement on hair loss in women. Journal of Cosmetic Dermatology, 14(1), 76–82. https://doi.org/10.1111/jocd.12127

Leaf, A. (2008). Historical overview of n-3 fatty acids and coronary heart disease. The American Journal of Clinical Nutrition, 87(6), 1978S-80S. https://doi.org/10.1093/ajcn/87.6.1978S

Levant, B. (2011). N-3 (Omega-3) fatty acids in postpartum depression: Implications for prevention and treatment. Depression Research and Treatment, 2011, 467349. https://doi.org/10.1155/2011/467349

Li, J., Xun, P., Zamora, D., Sood, A., Liu, K., Daviglus, M., Iribarren, C., Jacobs, D., Shikany, J. M., & He, K. (2013). Intake of long-chain omega-3 (n-3) PUFAs and fish in relation to incidence of asthma among American young adults: The CARDIA study. The American Journal of Clinical Nutrition, 97(1), 181–186. https://doi.org/10.3945/ajcn.112.041145

Li, L., & Leung, P. S. (2017). Chapter 13 – Pancreatic cancer, pancreatitis, and oxidative stress. In W. J. Gracia-Sancho & J. Salvadó (Eds.), Gastrointestinal Tissue (pp. 173–186). Academic Press. https://doi.org/10.1016/B978-0-12-805377-5.00012-6

Liao, Y., Xie, B., Zhang, H., He, Q., Guo, L., Subramanieapillai, M., Fan, B., Lu, C., & McIntyre, R. S. (2019). Efficacy of omega-3 PUFAs in depression: A meta-analysis. Translational Psychiatry, 9, 190. https://doi.org/10.1038/s41398-019-0515-5

Linday, L. A. (2010). Cod liver oil, young children, and upper respiratory tract infections. Journal of the American College of Nutrition, 29(6), 559–562. https://doi.org/10.1080/07315724.2010.10719894

Liu, G., Liu, J., Pian, L., Gui, S., & Lu, B. (2019). α-Lipoic acid protects against carbon tetrachloride-induced liver cirrhosis through the suppression of the TGF-β/Smad3 pathway and autophagy. Molecular Medicine Reports, 19(2), 841–850. https://doi.org/10.3892/mmr.2018.9719

Löfvenborg, J. E., Andersson, T., Carlsson, P.-O., Dorkhan, M., Groop, L., Martinell, M., Tuomi, T., Wolk, A., & Carlsson, S. (2014). Fatty fish consumption and risk of latent autoimmune diabetes in adults. Nutrition & Diabetes, 4(10), e139. https://doi.org/10.1038/nutd.2014.36

Lordan, S., Ross, R. P., & Stanton, C. (2011). Marine bioactives as functional food ingredients: Potential to reduce the incidence of chronic diseases. Marine Drugs, 9(6), 1056–1100. https://doi.org/10.3390/md9061056

Mano, Y., Kato, A., Fukuda, N., Yamada, K., & Yanagimoto, K. (2022). Influence of ingestion of eicosapentaenoic acid-rich fish oil on oxidative stress at the menstrual phase: A randomised, double-blind, placebo-controlled, parallel-group trial. Women’s Health Reports, 3(1), 643–651. https://doi.org/10.1089/whr.2022.0003

Marine Oils. (2006). In Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development. http://www.ncbi.nlm.nih.gov/books/NBK501898/

Mark, B. J., Beaty, A. D., & Slavin, R. G. (2008). Are fish oil supplements safe in finned fish-allergic patients? Allergy and Asthma Proceedings, 29(5), 528–529. https://doi.org/10.2500/aap.2008.29.3159

Marklund, M., Wu, J. H. Y., Imamura, F., Del Gobbo, L. C., Fretts, A., de Goede, J., Shi, P., Tintle, N., Wennberg, M., Aslibekyan, S., Chen, T.-A., de Oliveira Otto, M. C., Hirakawa, Y., Eriksen, H. H., Kröger, J., Laguzzi, F., Lankinen, M., Murphy, R. A., Prem, K., & null, null. (2019). Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality. Circulation, 139(21), 2422–2436. https://doi.org/10.1161/CIRCULATIONAHA.118.038908

Martins, J. G. (2009). EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: Evidence from a meta-analysis of randomised controlled trials. Journal of the American College of Nutrition, 28(5), 525–542. https://doi.org/10.1080/07315724.2009.10719785

McNamara, R. K. (2016). Role of omega-3 fatty acids in the aetiology, treatment, and prevention of depression: Current status and future directions. Journal of Nutrition & Intermediary Metabolism, 5, 96–106. https://doi.org/10.1016/j.jnim.2016.04.004

Merle, B., Delyfer, M.-N., Korobelnik, J.-F., Rougier, M.-B., Colin, J., Malet, F., Féart, C., Le Goff, M., Dartigues, J.-F., Barberger-Gateau, P., & Delcourt, C. (2011). Dietary omega-3 fatty acids and the risk for age-related maculopathy: The Alienor Study.